Emergent BioSolutions SG&A Expense (TTM) Trends

Emergent BioSolutions Inc (EBS)

6.82 -0.16 (-2.29%) USD | NYSE | Jun 28, 16:00

6.82 0.00 (0.00%) Pre-Market: 06:40

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2007. Upgrade now.

Date	Value
March 31, 2024	351.80M
December 31, 2023	368.40M
September 30, 2023	372.10M
June 30, 2023	367.90M
March 31, 2023	357.60M
December 31, 2022	341.10M
September 30, 2022	342.20M
June 30, 2022	342.50M
March 31, 2022	352.60M
December 31, 2021	348.70M
September 30, 2021	337.10M
June 30, 2021	330.50M
March 31, 2021	315.30M
December 31, 2020	304.10M
September 30, 2020	293.40M
June 30, 2020	282.90M
March 31, 2020	277.70M
December 31, 2019	273.40M
September 30, 2019	281.90M
June 30, 2019	259.00M
March 31, 2019	227.70M
December 31, 2018	202.30M
September 30, 2018	162.98M
June 30, 2018	155.38M
March 31, 2018	147.75M

Date	Value
December 31, 2017	142.90M
September 30, 2017	136.29M
June 30, 2017	142.48M
March 31, 2017	146.54M
December 31, 2016	143.10M
September 30, 2016	143.21M
June 30, 2016	128.32M
March 31, 2016	128.85M
December 31, 2015	131.63M
September 30, 2015	114.40M
June 30, 2015	118.90M
March 31, 2015	113.00M
December 31, 2014	108.59M
September 30, 2014	116.34M
June 30, 2014	108.00M
March 31, 2014	97.94M
December 31, 2013	87.88M
September 30, 2013	81.96M
June 30, 2013	79.16M
March 31, 2013	76.55M
December 31, 2012	76.02M
September 30, 2012	74.80M
June 30, 2012	73.07M
March 31, 2012	75.56M
December 31, 2011	74.28M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

273.40M

Minimum

Dec 2019

372.10M

Maximum

Sep 2023

328.48M

Average

341.10M

Median

Dec 2022

SG&A Expense (TTM) Benchmarks